We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-14.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
-$1.44B
Cap. Flow
-$114M
Cap. Flow %
-1.78%
Top 10 Hldgs %
23.74%
Holding
150
New
4
Increased
49
Reduced
28
Closed
15

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$29.2M
2
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$28.5M
3
LNG icon
Cheniere Energy
LNG
+$27.5M
4
PANW icon
Palo Alto Networks
PANW
+$26.5M
5
APTV icon
Aptiv
APTV
+$24.3M

Top Sells

Rank Stock Value
1
W icon
Wayfair
W
+$63.5M
2
MGA icon
Magna International
MGA
+$61.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$48.6M
4
ASML icon
ASML
ASML
+$34.6M
5
YETI icon
Yeti Holdings
YETI
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 33.31%
2 Technology 29.3%
3 Industrials 14.62%
4 Consumer Discretionary 5.73%
5 Utilities 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNG icon
51
Cheniere Energy
LNG
$54.1B
$40.5M 0.64%
292,400
+226,500
+344% +$27.5M
NOVT icon
52
Novanta
NOVT
$4.95B
$39.8M 0.62%
280,000
– –
MDB icon
53
MongoDB
MDB
$26.2B
$39.6M 0.62%
89,355
– –
SMAR
54
DELISTED
Smartsheet Inc.
SMAR
$38.2M 0.6%
697,000
+19,000
+3% +$1.09M
BPMC
55
DELISTED
Blueprint Medicines
BPMC
$37.8M 0.59%
592,500
+196,700
+50% +$14.1M
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$37.3M 0.58%
453,781
+162,155
+56% +$16.6M
VRSK icon
57
Verisk Analytics
VRSK
$26.1B
$35.4M 0.56%
165,100
-47,900
-22% -$9.44M
ZYME icon
58
Zymeworks
ZYME
$1.67B
$35.2M 0.55%
5,380,200
+2,561,065
+91% +$22.8M
DICE
59
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$35.2M 0.55%
1,871,612
– –
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$350M
$35.1M 0.55%
761,000
+232,000
+44% +$12.5M
BEPC icon
61
Brookfield Renewable
BEPC
$6.04B
$33.9M 0.53%
775,019
– –
KURA icon
62
Kura Oncology
KURA
$826M
$33.1M 0.52%
2,061,044
+700,000
+51% +$10.1M
NVT icon
63
nVent Electric
NVT
$23.4B
$30.7M 0.48%
882,600
+50,400
+6% +$1.76M
IMVT icon
64
Immunovant
IMVT
$8.11B
$29.6M 0.46%
5,372,512
+422,512
+9% +$2.63M
COGT icon
65
Cogent Biosciences
COGT
$7.07B
$29.2M 0.46%
3,900,000
+385,091
+11% +$2.68M
ENPH icon
66
Enphase Energy
ENPH
$4.94B
$29.1M 0.46%
144,069
+77,569
+117% +$12.2M
ADCT icon
67
ADC Therapeutics
ADCT
$141M
$29M 0.45%
1,975,000
– –
LSCC icon
68
Lattice Semiconductor
LSCC
$17.7B
$28.8M 0.45%
471,744
– –
CGNX icon
69
Cognex
CGNX
$10.4B
$27.7M 0.43%
359,000
– –
STE icon
70
Steris
STE
$22.5B
$27.1M 0.43%
112,185
+14,200
+14% +$3.29M
VITL icon
71
Vital Farms
VITL
$536M
$27.1M 0.42%
2,190,051
-759,949
-26% -$11.4M
PLD icon
72
Prologis
PLD
$136B
$27M 0.42%
167,200
+6,600
+4% +$1.01M
MASS icon
73
908 Devices
MASS
$313M
$26.8M 0.42%
1,410,000
– –
NRIX icon
74
Nurix Therapeutics
NRIX
$2.45B
$26.2M 0.41%
1,870,000
– –
EPIX
75
DELISTED
ESSA Pharma
EPIX
$25.8M 0.4%
4,170,259
+851,612
+26% +$7.49M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Eventide Asset Management held 150 positions worth $6.38B, down 18% from $7.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2022 filing shows 4 new, 49 increased, 28 reduced and 15 closed positions. Its largest new stake was Walker & Dunlop: 121,935 shares worth $15.8M. The largest sale was Wayfair, an estimated $63.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2022 buy was Walker & Dunlop: 121,935 shares worth $15.8M.
  • Eventide Asset Management added most to Guardant Health in Q1 2022, an estimated $29.2M increase.
  • Eventide Asset Management's biggest Q1 2022 reduction was Ascendis Pharma A/S, cutting an estimated $48.6M.
  • Eventide Asset Management fully exited Wayfair in Q1 2022, selling an estimated $63.5M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2022.
  • Eventide Asset Management opened 4 new positions and closed 15 in Q1 2022.
  • Eventide Asset Management's portfolio value fell 18% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2022, filed 16 May 2022.